D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 73 Citations 20,630 292 World Ranking 465 National Ranking 24
Medicine D-index 90 Citations 32,270 468 World Ranking 5999 National Ranking 280

Research.com Recognitions

Awards & Achievements

Fellow of the European Confederation of Medical Mycology (ECMM)

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Surgery
  • Cancer

Oliver A. Cornely spends much of his time researching Internal medicine, Surgery, Voriconazole, Neutropenia and Posaconazole. He has included themes like Amphotericin B, Gastroenterology, Fluconazole, Mycosis and Aspergillosis in his Internal medicine study. His Surgery research includes elements of Clostridium difficile, Vancomycin, Fidaxomicin and Adverse effect.

His research in Voriconazole tackles topics such as Hematopoietic stem cell transplantation which are related to areas like Cumulative incidence. His Neutropenia study combines topics from a wide range of disciplines, such as Immunology, Pharmacokinetics and Leukopenia. In his research, Zygomycosis is intimately related to Mucormycosis, which falls under the overarching field of Posaconazole.

His most cited work include:

  • Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia (1305 citations)
  • Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. (763 citations)
  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. (751 citations)

What are the main themes of his work throughout his whole career to date?

Oliver A. Cornely mainly investigates Internal medicine, Intensive care medicine, Aspergillosis, Surgery and Posaconazole. His biological study deals with issues like Voriconazole, which deal with fields such as Amphotericin B. His research investigates the connection with Intensive care medicine and areas like Hematology which intersect with concerns in Cancer.

Oliver A. Cornely combines subjects such as Aspergillus fumigatus, Bronchoalveolar lavage, Polymerase chain reaction and Aspergillus with his study of Aspergillosis. His studies in Surgery integrate themes in fields like Adverse effect and Incidence. His biological study spans a wide range of topics, including Mucormycosis and Pharmacokinetics, Pharmacology.

He most often published in these fields:

  • Internal medicine (47.14%)
  • Intensive care medicine (22.53%)
  • Aspergillosis (18.02%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (47.14%)
  • Aspergillosis (18.02%)
  • Intensive care medicine (22.53%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Aspergillosis, Intensive care medicine, Voriconazole and Epidemiology. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Amphotericin B. His Aspergillosis research incorporates themes from Azole, Multicenter study, Aspergillus, Hematological malignancy and Bronchoalveolar lavage.

His work deals with themes such as Pulmonary aspergillosis, Severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019 and MEDLINE, which intersect with Intensive care medicine. His study in Voriconazole is interdisciplinary in nature, drawing from both Clinical research and Lung. In his research on the topic of Epidemiology, Mucormycosis and Pediatrics is strongly related with Mortality rate.

Between 2018 and 2021, his most popular works were:

  • COVID-19 associated pulmonary aspergillosis. (157 citations)
  • Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. (121 citations)
  • Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans. (119 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

His main research concerns Internal medicine, Voriconazole, Intensive care medicine, Aspergillosis and Coronavirus disease 2019. The Internal medicine study combines topics in areas such as Mucormycosis and Amphotericin B. His research in Amphotericin B intersects with topics in Fluconazole, Fungemia and Drug.

His Voriconazole study incorporates themes from Lung, Combination therapy, Terbinafine and Medical record. His Intensive care medicine research is multidisciplinary, incorporating elements of Epidemiology, Adult patients and Disease. His Aspergillosis research includes themes of ARDS, Microbiology, Mucorales, Superinfection and Bronchoalveolar lavage.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

Oliver A. Cornely;Johan Maertens;Drew J. Winston;John Perfect.
The New England Journal of Medicine (2007)

1730 Citations

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.

Thomas J Walsh;Hedy Teppler;Gerald R Donowitz;Johan A Maertens.
The New England Journal of Medicine (2004)

1087 Citations

ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

O.A. Cornely;M. Bassetti;T. Calandra;J. Garbino.
Clinical Microbiology and Infection (2012)

1024 Citations

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

Ernst-Ruediger Kuse;Ploenchan Chetchotisakd;Clovis Arns da Cunha;Markus Ruhnke.
The Lancet (2007)

801 Citations

Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial

Oliver A Cornely;Derrick W Crook;Roberto Esposito;André Poirier.
Lancet Infectious Diseases (2012)

721 Citations

Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High–Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

Oliver A. Cornely;Johan Maertens;Mark Bresnik;Ramin Ebrahimi.
Clinical Infectious Diseases (2007)

720 Citations

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Johan A. Maertens;Issam I. Raad;Kieren A. Marr;Thomas F. Patterson.
The Lancet (2016)

605 Citations

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning.
Clinical Microbiology and Infection (2018)

563 Citations

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

J Maertens;O Marchetti;R Herbrecht;O A Cornely.
Bone Marrow Transplantation (2011)

544 Citations

ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of mucormycosis 2013

O.A. Cornely;S. Arikan-Akdagli;E. Dannaoui;A.H. Groll.
Clinical Microbiology and Infection (2014)

543 Citations

Editorial Boards

Mycoses
(Impact Factor: 4.931)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Oliver A. Cornely

Thomas J. Walsh

Thomas J. Walsh

Weill Cornell Medicine

Publications: 141

Paul E. Verweij

Paul E. Verweij

Radboud University Nijmegen

Publications: 130

Monica A. Slavin

Monica A. Slavin

Peter MacCallum Cancer Centre

Publications: 126

Jacques F. Meis

Jacques F. Meis

Canisius-Wilhelmina Ziekenhuis

Publications: 118

Dimitrios P. Kontoyiannis

Dimitrios P. Kontoyiannis

The University of Texas MD Anderson Cancer Center

Publications: 112

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 97

Olivier Lortholary

Olivier Lortholary

Université Paris Cité

Publications: 92

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 90

Patricia Muñoz

Patricia Muñoz

Hospital General Universitario Gregorio Marañón

Publications: 89

Mark H. Wilcox

Mark H. Wilcox

University of Leeds

Publications: 81

Andreas H. Groll

Andreas H. Groll

Boston Children's Hospital

Publications: 79

Emmanuel Roilides

Emmanuel Roilides

Aristotle University of Thessaloniki

Publications: 76

Nathan P. Wiederhold

Nathan P. Wiederhold

The University of Texas Health Science Center at San Antonio

Publications: 74

Emilio Bouza

Emilio Bouza

Hospital General Universitario Gregorio Marañón

Publications: 74

Livio Pagano

Livio Pagano

Catholic University of the Sacred Heart

Publications: 74

Sharon C.-A. Chen

Sharon C.-A. Chen

University of Sydney

Publications: 73

Trending Scientists

Sally Dibb

Sally Dibb

Coventry University

R. Quentin Grafton

R. Quentin Grafton

Australian National University

Mark Gross

Mark Gross

University of Cambridge

Hans C. Andersen

Hans C. Andersen

Stanford University

Akkattu T. Biju

Akkattu T. Biju

Indian Institute of Science

Dale R. Nyholt

Dale R. Nyholt

Queensland University of Technology

Michael J. Angilletta

Michael J. Angilletta

Arizona State University

Brian Kuhlman

Brian Kuhlman

University of North Carolina at Chapel Hill

Charles L. Guy

Charles L. Guy

University of Florida

Jim Gray

Jim Gray

Government of the United Kingdom

Margaret E. Conner

Margaret E. Conner

Baylor College of Medicine

Robert Marsh

Robert Marsh

University of Southampton

Peter A. E. M. Janssen

Peter A. E. M. Janssen

European Centre for Medium-Range Weather Forecasts

Marie-Aurélie Bruno

Marie-Aurélie Bruno

University of Liège

Richard K. Winkelmann

Richard K. Winkelmann

Mayo Clinic

Arnold Ganser

Arnold Ganser

Hannover Medical School

Something went wrong. Please try again later.